JPMorgan Chase & Co’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-33,682
| Closed | -$61K | – | 6733 |
|
|
2023
Q2 | $61K | Sell |
33,682
-19,903
| -37% | -$36K | ﹤0.01% | 4817 |
|
|
2023
Q1 | $71K | Buy |
53,585
+33,719
| +170% | +$44.7K | ﹤0.01% | 4783 |
|
|
2022
Q4 | $34K | Buy |
19,866
+1,253
| +7% | +$2.14K | ﹤0.01% | 4840 |
|
|
2022
Q3 | $34K | Buy |
18,613
+3,463
| +23% | +$6.33K | ﹤0.01% | 4805 |
|
|
2022
Q2 | $47K | Buy |
+15,150
| New | +$47K | ﹤0.01% | 4869 |
|